focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMDL.L Regulatory News (RMDL)

  • There is currently no data for RMDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: RM Secured Direct Lending (RMDL): Predictable revenue streams generating high yield

5 Jun 2019 09:22

Hardman & Co Research Hardman & Co Research: RM Secured Direct Lending (RMDL): Predictable revenue streams generating high yield 05-Jun-2019 / 09:21 GMT/BST


Hardman & Co Research: Predictable revenue streams generating high yield

THIS DOCUMENT IS NOT AVAILABLE TO 'U.S. PERSONS', NOR TO PARTIES WHO ARE NOT CONSIDERED 'RELEVANT PERSONS' IN THE UNITED KINGDOM, NOR SHOULD IT BE TAKEN, TRANSMITTED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, TO EITHER OF THESE CATEGORIES. SEE PAGE 3 FOR FURTHER DETAILS.

RM Secured Direct Lending (RMDL) offers investors an ongoing ca.6.5% dividend yield, whose sustainability is supported by multi-year assets, a rising revenue yield and economies of scale. Credit, we believe, is well controlled, and we provide readers with a detailed review of its assessment, monitoring and recovery. We believe the gearing level is appropriate, the investment manager's interests are aligned to shareholders, and that any discount will be actively managed. Like any lender, there are risks when the cycle turns; also, RMDL has some junior debt positions, and its book has shown a propensity to turn over, which in the future could see more external refinancing. The shares trade at a 3% premium to NAV. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/predictable-revenue-streams-generating-high-yield/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contacts: Mark Thomas +44 20 7194 7622 mt@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

819689 05-Jun-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
13th Aug 20187:00 amRNSCapital Markets Day
10th Aug 20187:01 amRNSHalf-year Report
10th Aug 20187:00 amRNSHalf-year Report
9th Aug 20187:00 amRNSHoldings in Company and Total Voting Rights
7th Aug 20183:14 pmRNSDividend Declaration
1st Aug 20185:41 pmRNSTotal Voting Rights
16th Jul 20185:20 pmRNSRM Secured Direct Lending
16th Jul 20187:00 amRNSNet Asset Value(s)
16th Jul 20187:00 amRNSC Share Conversion Ratio
16th Jul 20187:00 amRNSQuarterly Update
28th Jun 20184:36 pmRNSHolding(s) in Company
22nd Jun 20183:48 pmRNSConversion of C Shares
18th Jun 20187:00 amRNSNet Asset Value(s)
25th May 20185:23 pmRNSHolding(s) in Company
24th May 20187:00 amRNSDividend Declaration
16th May 20187:00 amRNSNet Asset Value(s)
19th Apr 20182:03 pmRNSResult of AGM
16th Apr 20185:25 pmRNSHoldings in the Company and TVR
16th Apr 20187:25 amRNSQuarterly Update
16th Apr 20187:25 amRNSNet Asset Value(s)
5th Apr 20186:26 pmRNSHolding(s) in Company
3rd Apr 20186:15 pmRNSHolding(s) in Company
3rd Apr 20188:28 amRNSDirector/PDMR Shareholding
28th Mar 201812:57 pmRNSResult of General Meeting
27th Mar 20186:15 pmRNSResult of Share Issues
21st Mar 20188:45 amRNSHolding(s) in Company
14th Mar 20187:00 amRNSNet Asset Value(s)
14th Mar 20187:00 amRNSC Share Conversion Ratio
12th Mar 20183:11 pmRNSCapital Raising and Publication of Prospectus
9th Mar 20182:00 pmRNSAnnual Financial Report
5th Mar 20184:41 pmRNSCircular and Notice of General Meeting
15th Feb 20187:01 amRNSConversion of C Shares and Further Capital
15th Feb 20187:00 amRNSNet Asset Value(s)
15th Feb 20187:00 amRNSDividend Declaration
16th Jan 20183:29 pmRNSHoldings in the Company and TVR
16th Jan 20187:01 amRNSQuarterly Update
16th Jan 20187:00 amRNSNet Asset Value(s)
8th Jan 20187:00 amRNSPortfolio Update
18th Dec 20177:00 amRNSNet Asset Value(s)
23rd Nov 20173:00 pmRNSDividend Declaration
16th Nov 20177:00 amRNSNet Asset Value(s)
7th Nov 20177:00 amRNSRevolving Credit Facility
1st Nov 20177:00 amRNSTotal Voting Rights
30th Oct 20174:12 pmRNSHolding(s) in Company
26th Oct 20175:59 pmRNSHolding(s) in Company
19th Oct 20173:59 pmRNSResult of Placing under Placing Programme
18th Oct 20177:00 amRNSPlacing under Placing Programme
16th Oct 201711:30 amRNSHoldings in the Company and TVR
16th Oct 20177:01 amRNSQuarterly Update
16th Oct 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.